loadpatents
name:-0.033963918685913
name:-0.028133869171143
name:-0.027064085006714
TEOBALD; Barry John Patent Filings

TEOBALD; Barry John

Patent Applications and Registrations

Patent applications and USPTO patent grants for TEOBALD; Barry John.The latest application filed is for "itaconic acid derivatives and uses thereof intreating an inflammatory disease or a disease associated with an undesirable immune response".

Company Profile
16.16.21
  • TEOBALD; Barry John - Oxfordshire GB
  • Teobald; Barry John - Cambridge GB
  • Teobald; Barry John - Welwyn Garden City GB
  • Teobald; Barry John - Welwyn Garden GB
  • Teobald; Barry John - Leicestershire GB
  • Teobald; Barry John - Loughborough GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Itaconic Acid Derivatives And Uses Thereof Intreating An Inflammatory Disease Or A Disease Associated With An Undesirable Immune Response
App 20220265595 - COOKE; Michael Liam ;   et al.
2022-08-25
Pharmaceutical compounds
Grant 11,352,342 - Brown , et al. June 7, 2
2022-06-07
Pharmaceutical compounds
Grant 11,319,312 - Brown , et al. May 3, 2
2022-05-03
Muscarinic agonists
Grant 11,254,656 - Brown , et al. February 22, 2
2022-02-22
Bicyclic Aza Compounds As Muscarinic M1 And/or M4 Receptor Agonists
App 20210387969 - Brown; Giles Albert ;   et al.
2021-12-16
Pyrazole Derivatives As H4 Antagonist Compounds
App 20210300906 - Brown; Giles Albert ;   et al.
2021-09-30
Inhibitors of protease-activated receptor-2
Grant 10,995,072 - Cumming , et al. May 4, 2
2021-05-04
Pharmaceutical Compounds
App 20210101893 - Brown; Giles Albert ;   et al.
2021-04-08
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor
Grant 10,961,225 - Brown , et al. March 30, 2
2021-03-30
Pharmaceutical Compounds
App 20210040067 - Brown; Giles Albert ;   et al.
2021-02-11
Pharmaceutical Compounds
App 20210002271 - Brown; Giles Albert ;   et al.
2021-01-07
Pharmaceutical compounds
Grant 10,858,352 - Brown , et al. December 8, 2
2020-12-08
Muscarinic Agonists
App 20200354339 - Brown; Giles Albert ;   et al.
2020-11-12
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor
App 20200325118 - Brown; Giles Albert ;   et al.
2020-10-15
Pharmaceutical compounds
Grant 10,787,447 - Brown , et al. September 29, 2
2020-09-29
Pharmaceutical compounds
Grant 10,752,610 - Brown , et al. A
2020-08-25
Muscarinic agonists
Grant 10,738,029 - Brown , et al. A
2020-08-11
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor
Grant 10,689,368 - Brown , et al.
2020-06-23
Inhibitors Of Protease-activated Receptor-2
App 20200140392 - Cumming; John Graham ;   et al.
2020-05-07
Inhibitors of protease-activated receptor-2
Grant 10,550,089 - Cumming , et al. Fe
2020-02-04
Pharmaceutical Compounds
App 20200002328 - Brown; Giles Albert ;   et al.
2020-01-02
Pharmaceutical Compounds
App 20190389849 - Brown; Giles Albert ;   et al.
2019-12-26
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor
App 20190337925 - Brown; Giles Albert ;   et al.
2019-11-07
Pharmaceutical Compounds
App 20190276437 - Brown; Giles Albert ;   et al.
2019-09-12
Bicyclic aza compounds as muscarnic M1 receptor and/or M4 receptor antagonists
Grant 10,385,039 - Brown , et al. A
2019-08-20
Pharmaceutical compounds
Grant 10,329,278 - Brown , et al.
2019-06-25
Inhibitors Of Protease-activated Receptor-2
App 20190144394 - Cumming; John Graham ;   et al.
2019-05-16
Bicyclic Aza Compounds As Muscarnic M1 Receptor And/or M4 Receptor Antagonists
App 20190112294 - Brown; Giles Albert ;   et al.
2019-04-18
Bicyclic aza compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 10,196,380 - Brown , et al. Fe
2019-02-05
Pharmaceutical Compounds
App 20180362507 - Brown; Giles Albert ;   et al.
2018-12-20
Muscarinic Agonists
App 20180222885 - Brown; Giles Albert ;   et al.
2018-08-09
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists
App 20180179184 - Brown; Giles Albert ;   et al.
2018-06-28
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 9,926,297 - Brown , et al. March 27, 2
2018-03-27
Bicyclic Aza Compounds As Muscarinic M1 Receptor And/or M4 Receptor Agonists
App 20170240530 - Brown; Giles Albert ;   et al.
2017-08-24
Bicyclic AZA compounds as muscarinic M1 receptor and/or M4 receptor agonists
Grant 9,670,183 - Brown , et al. June 6, 2
2017-06-06
Compouds
App 20120322788 - Alcaraz; Lilian ;   et al.
2012-12-20
Compounds
App 20090298807 - Alcaraz; Lilian ;   et al.
2009-12-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed